Exact Sciences Cor (EXAS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EXAS | GMAB | JAZZ | ||
| Company | Exact Sciences Cor | Genmab A/S ADR | Jazz Pharma Plc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 104.93 | 33.78 | 249.48 | ||
| High | 104.98 | 33.93 | 250.64 | ||
| Low | 104.90 | 33.52 | 245.00 | ||
| Last | 104.91 | 33.50 | 248.06 | ||
| Change | +0.99 | -0.60 | -3.04 | ||
| Percent Change | +0.95% | -1.76% | -1.21% | ||
| Volume | 21,562,100 | 452,471 | 525,869 | ||
| 20-Day Average Volume | 3,124,595 | 2,871,145 | 1,080,989 | ||
| Previous | 103.92 | 34.10 | 251.10 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 103.57 | 32.01 | 252.53 | ||
| 20-Day Raw Stochastic | 96.55% | 88.40% | 23.85% | ||
| 20-Day Relative Strength | 75.93 | 65.81 | 48.73 | ||
| Weighted Alpha | +85.47 | +37.42 | +81.83 | ||
| Today's Opinion | 100% Buy | 88% Buy | 72% Buy | ||
| Yesterday's Opinion | 100% Buy | 88% Buy | 88% Buy | ||
| Last Month's Opinion | 100% Buy | 8% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.29% since 03/13/26 | +0.84% since 08/21/26 | -2.95% since 08/21/26 | ||
| Low | 103.60 on 03/16/26 | 32.74 on 08/24/26 | 245.00 on 08/28/26 | ||
| High | 104.98 on 03/20/26 | 34.47 on 08/25/26 | 266.38 on 08/25/26 | ||
| 1-Month | |||||
| %Chg | +1.43% since 02/20/26 | +16.31% since 07/28/26 | -3.95% since 07/28/26 | ||
| Low | 102.95 on 02/27/26 | 28.03 on 07/30/26 | 240.63 on 08/14/26 | ||
| High | 104.98 on 03/20/26 | 34.47 on 08/25/26 | 266.38 on 08/25/26 | ||
| 3-Month | |||||
| %Chg | +3.03% since 12/19/25 | +24.74% since 05/28/26 | +4.84% since 05/28/26 | ||
| Low | 101.44 on 12/23/25 | 23.62 on 06/03/26 | 220.74 on 06/18/26 | ||
| High | 104.98 on 03/20/26 | 34.47 on 08/25/26 | 266.38 on 08/25/26 | ||
| 6-Month | |||||
| %Chg | +96.76% since 09/19/25 | +14.57% since 02/27/26 | +29.87% since 02/27/26 | ||
| Low | 51.75 on 09/24/25 | 23.62 on 06/03/26 | 176.67 on 03/06/26 | ||
| High | 104.98 on 03/20/26 | 34.47 on 08/25/26 | 266.38 on 08/25/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 20,026,062 | 21,262,476 | 16,300,158 | ||
| Shares Outstanding, K | 190,888 | 623,533 | 64,915 | ||
| Annual Sales, $M | 3,246,990,000 | 3,720,000,000 | 4,267,590,000 | ||
| Annual Net Income, $M | -207,950,000 | 963,000,000 | -356,150,000 | ||
| Last Qtr Sales, $M | 878,380,000 | 1,155,000,000 | 1,208,300,000 | ||
| Last Qtr Income, $M | -85,960,000 | 303,000,000 | 192,800,000 | ||
| 60-Month Beta | 1.41 | 0.83 | 0.32 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.21 on 02/13/26 | 0.54 on 08/06/26 | 5.71 on 08/03/26 | ||
| Latest Earnings Date | 05/07/26 | 11/05/26 | 11/04/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 2,598.00 | 24.28 | 10.79 | ||